Metabolic Diseases  >>  PF-06291874  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-06291874 / Pfizer
NCT01856595: PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients

Completed
1
117
US
PF-06291874, Placebo
Pfizer
Diabetes Mellitus, Type 2
01/14
03/14

Download Options